Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98026Q01240 in this department, oldest first.
- Sep 17, 2026 · this noticeCombined Synopsis/Solicitation
- Sep 17, 2026Combined Synopsis/SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Thomas Jefferson University to Obtain Clinical Cohort of Patients with Associated Clinical Outcomes, Radiologic Images, and Associated De-Identified Radiology Reports. In accordance with FAR 6.302-1, Only One Responsible Source and No Other Services Will Satisfy Agency Requirements, The requested clinical cohorts, radiographic imaging datasets, clinical outcomes data, and de-identified radiology reports are required to support artificial intelligence-based research focused on evaluating liver cancer r… (show all)
isk in patients with cirrhosis and indeterminate liver lesions. The research requires datasets that combine specific patient populations with associated imaging studies and clinical outcomes information to enable the development, validation, and evaluation of predictive models. Alternative datasets that do not include the required patient populations, imaging data, clinical outcomes information, and associated radiology reports would not provide the information necessary to support the approved research objectives. The absence of any of these data elements would limit the ability to correlate imaging findings with clinical outcomes and would reduce the scientific validity and reliability of the resulting analyses. Therefore, only datasets containing the required clinical cohorts and associated imaging and outcomes data will satisfy the Government's minimum needs and support the approved research objectives. The objectives of the maintenance agreement are as follows: The objective of this requirement is to acquire clinical patient cohorts, associated imaging data, clinical outcomes data, and de-identified radiology reports to support the development and evaluation of A.I. models for liver disease and liver cancer research conducted by the Liver Diseases Branch. A determination by the Government to compete this proposed acquisition based upon responses received to this notice is solely within the discretion of the Government. The proposed contractor maintains an existing cohort of patients with cirrhosis and associated radiographic images collected at six-month intervals, as well as an existing cohort of patients with cirrhosis and indeterminate liver lesions, including associated clinical outcomes data and radiographic images. These clinical cohorts and associated datasets represent a unique research resource available through the proposed contractor. The combination of longitudinal imaging data, clinical outcomes data, and radiographic images associated with these patient populations is available only through the proposed contractor. As a result, only the proposed contractor can provide the requested deliverables necessary to support the research project. It is anticipated that an award will be issued approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another vendor has the capability to meet this requirement. Please submit responses electronically to davisroshonna@mail.nih.gov no later than 9:00 a.m. EDT on September 25, 2026. Please reference Notice No. 75N98026Q01240 in the subject line of the response.
Who won similar work
11 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) Q301.
Single-winner award sizes (11): middle half $70K to $297K, median $157K; range $27K to $35.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| AZENTA US INC | 1 | $35.0M | Dec 2, 2024 |
| PSOMAGEN INC | 1 | $533K | Dec 31, 2024 |
| NEW YORK STEM CELL FOUNDATION INC | 1 | $362K | Sep 23, 2025 |
| BAYLOR MIRACA GENETICS LABORATORIES LLC | 1 | $232K | Sep 26, 2025 |
| THE BROAD INSTITUTE, INC | 1 | $215K | Sep 29, 2026 |
| NORGEN BIOTEK CORP | 1 | $157K | Sep 19, 2025 |
| KAISER FOUNDATION HOSPITALS 1 KAISER PLAZA 22ND FLOOR Oakland CA 94612 USA | 1 | $115K | Sep 22, 2025 |
| ProteinTech Group Inc | 1 | $90K | Sep 19, 2025 |
| GREENWOOD GENETIC CENTER INC | 1 | $49K | Sep 25, 2025 |
| HISTOSERV, INC | 1 | $29K | May 5, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Sep 29, 2026THE BROAD INSTITUTE, INC$215KWhole genome sequencing for investigation of age-related chronic disease in HANDLS participantsNo listed company matched (Materiality N/A)
- Sep 26, 2025BAYLOR MIRACA GENETICS LABORATORIES LLC$232KQ--Clinical TestingNo listed company matched (Materiality N/A)
- Sep 25, 2025GREENWOOD GENETIC CENTER INC$49KQ--Genetic Testing with Greenwood Genetic Center IncNo listed company matched (Materiality N/A)
- Sep 23, 2025NEW YORK STEM CELL FOUNDATION INC$362KQ--iPSC Generation and Beta Cell DifferentiationNo listed company matched (Materiality N/A)
- Sep 22, 2025KAISER FOUNDATION HOSPITALS 1 KAISER PLAZA 22ND FLOOR Oakland CA 94612 USA$115KQ--Adherence with continuous positive airwayNo listed company matched (Materiality N/A)
- Sep 19, 2025NORGEN BIOTEK CORP$157KQ--Small RNA characterization of urinary exosomesNo listed company matched (Materiality N/A)
- Sep 19, 2025ProteinTech Group Inc$90KCRO Services for Single-Cell Multiomics ProfilingNo listed company matched (Materiality N/A)
- Jul 24, 2025ADVANCED CELL DIAGNOSTICS, INC.$27KQ--RNAscope In-House AssayMateriality: <0.01% of $TECH revenue (Low) SEC
- May 5, 2025HISTOSERV, INC$29KSignatures of aging outcomesNo listed company matched (Materiality N/A)
- Dec 31, 2024PSOMAGEN INC$533KLong read sequencing servicesNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (7 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.